Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis
Abstract Altered composition of gut bacteria and changes to the production of their bioactive metabolites, the short-chain fatty acids (SCFAs), have been implicated in the development of multiple sclerosis (MS). However, the immunomodulatory actions of SCFAs and intermediaries in their ability to in...
Guardado en:
Autores principales: | Stephanie Trend, Jonatan Leffler, Anderson P. Jones, Lilian Cha, Shelley Gorman, David A. Brown, Samuel N. Breit, Allan G. Kermode, Martyn A. French, Natalie C. Ward, Prue H. Hart |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/446d312c907640fc9a1032b9313f271d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum neurotrophin profile in systemic sclerosis.
por: Marie-Claude Lise, et al.
Publicado: (2010) -
Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
por: Simon Thebault, et al.
Publicado: (2020) -
Serum GFAP as a biomarker for disease severity in multiple sclerosis
por: A. Abdelhak, et al.
Publicado: (2018) -
Serum Nonesterified Fatty Acids and Incident Stroke: The CHS
por: Neil K. Huang, et al.
Publicado: (2021) -
The associations between serum adiponectin, leptin, C-reactive protein, insulin, and serum long-chain omega-3 fatty acids in Labrador Retrievers
por: Streeter RM, et al.
Publicado: (2015)